Schedule 13G ownership disclosure

AGEX THERAPEUTICS INC

Security class unavailable · CUSIP: 00848H108

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,400,000
Percent of class
45.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-006403
Form type
SC 13G
Filer
Serina Therapeutics, Inc.
CIK
CIK 1708599
Filed
Feb 12, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub